🇪🇺 Libtayo in European Union

EMA authorised Libtayo on 28 June 2019

Marketing authorisation

EMA — authorised 28 June 2019

  • Marketing authorisation holder: REGENERON IRELAND U.C.
  • Status: approved

Libtayo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Libtayo approved in European Union?

Yes. EMA authorised it on 28 June 2019.

Who is the marketing authorisation holder for Libtayo in European Union?

REGENERON IRELAND U.C. holds the EU marketing authorisation.